early or unresectable advanced gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Histologically confirmed gastric cancer. 2) Patients informed diagnosis of their disease. 3) Aged from 20 over years. 4) Grade 0 to 2 in performance status (ECOG). 5) In early gastric cancer patients, patients with confirmed the curative resection with endoscopic treatment. 6) In advanced gastric cancer patients, patients who are scheduled to newly primary chemotherapy. 7) Expected to be alive at least six months after informed consent in advanced gastric cancer patients. 8) Having written informed consent.
Exclusion criteria
Exclusion criteria: 1) Presence of severe complications (heart failure, liver desease, renal desease). 2) Presence of infectious disease. 3) Taking the drug affecting immune system such as steroid and immunosuppresant. 4) Taking the supplement affecting immune system. 5) Inappropriate patients for study judged by the physicians.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess immune monitoring such as cytokines, QOL evaluation and intestinal flora analysis. | — |
Countries
Japan
Contacts
Kyoto Prefectural University of Medicine Molecular Gastroenterology and Hepatology